We are live on ! Find out more
AMYT

Amryt Pharma plc American Depositary Shares

Delisted

AMYT was delisted on the 11th of April, 2023.

29 hedge funds and large institutions have $209M invested in Amryt Pharma plc American Depositary Shares in 2021 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 5 increasing their positions, 0 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,400% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 1

93% more funds holding

Funds holding: 1529 (+14)

12% more capital invested

Capital invested by funds: $186M → $209M (+$22.4M)

0% more funds holding in top 10

Funds holding in top 10: 44 (0)

Holders
29
Holders Change
+14
Holders Change %
+93.33%
% of All Funds
0.51%
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.07%
New
15
Increased
5
Reduced
Closed
1
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
ACM
1
Athyrium Capital Management
New York
$63M
SCM
2
Stonepine Capital Management
Oregon
$35.2M +$15.5M +1,107,245 +78%
EIG
3
EdgePoint Investment Group
Ontario, Canada
$31.9M +$4.2M +300,905 +15%
UOC
4
UBS O'Connor
Illinois
$27.7M
HCM
5
Highbridge Capital Management
New York
$14.1M +$2.6M +185,994 +23%
ACM
6
Aquilo Capital Management
California
$11.1M
SCM
7
Silverarc Capital Management
Massachusetts
$5.99M +$382K +27,307 +7%
Ameriprise
8
Ameriprise
Minnesota
$3.8M
WA
9
Whitebox Advisors
Minnesota
$3.7M
AC
10
Armistice Capital
New York
$2.79M
MIM
11
Monashee Investment Management
Massachusetts
$2.79M
HVC
12
Healthcare Value Capital
New Jersey
$2.17M +$2.17M +155,555 New
GFI
13
Global Frontier Investments
South Carolina
$1.74M
NAM
14
Nexpoint Asset Management
Texas
$1.11M
CCM
15
Context Capital Management
California
$1.08M +$113K +8,059 +12%
TI
16
Telemetry Investments
New York
$524K +$526K +37,652 New
Acadian Asset Management
17
Acadian Asset Management
Massachusetts
$7K +$7.25K +519 New
AIM
18
Axiom Investment Management
New York
$4K +$3.87K +277 New
Bank of Montreal
19
Bank of Montreal
Ontario, Canada
$2K +$1.59K +114 New
Royal Bank of Canada
20
Royal Bank of Canada
Ontario, Canada
$1K +$601 +43 New
JP Morgan Chase
21
JP Morgan Chase
New York
$1K +$922 +66 New
Morgan Stanley
22
Morgan Stanley
New York
$1K +$1.06K +76 New
FDCDDQ
23
Federation des caisses Desjardins du Quebec
Quebec, Canada
$56 +$56 +4 New
Citigroup
24
Citigroup
New York
-$2K -138 Closed
UBS Group
25
UBS Group
Switzerland
+$28 +2 New

AMYT Hedge Fund Activity: Q1 2021 in Review

29 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Amryt Pharma plc American Depositary Shares (AMYT) for Q1 2021, worth a combined $209M — up 12% from $186M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new AMYT positions and 1 closed out — a net gain of 14 holders — while 5 added to existing stakes and 0 trimmed.

The largest buyer was Stonepine Capital Management, adding an estimated $15.5M. The largest seller was Citigroup, exiting entirely with an estimated $2K sold.

  • 29 institutional investors held Amryt Pharma plc American Depositary Shares (AMYT) as of Q1 2021, up from 15 in Q4 2020.
  • Funds reported $209M of Amryt Pharma plc American Depositary Shares stock for Q1 2021, up 12% quarter-over-quarter.
  • 15 funds opened new Amryt Pharma plc American Depositary Shares positions in Q1 2021 and 1 closed out, a net change of +14 holders.
  • The largest Amryt Pharma plc American Depositary Shares buyer in Q1 2021 was Stonepine Capital Management, an estimated $15.5M added.
  • The largest Amryt Pharma plc American Depositary Shares seller in Q1 2021 was Citigroup, an estimated $2K sold.

Based on aggregated 13F filings for Q1 2021.